Effects of (-)-epigallocatechin gallate on the development of morphine-induced physical dependence

Archives of Pharmacal Research

Volumn 30, Issue 9, 2007, Pages 1111-1115

  Oh, Ki Wan ^a   Jae, Soon Eun ^b   Kwon, Han Na ^a   Cho, Eun Young ^c   Kim, Kyeong Man ^c  

^a Chungbuk National University   (South Korea)

^b Woosuk University   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

( ) Epigallocatechin gallate (EGCG); Dopamine D2 receptor; Morphine withdrawal symptoms

Indexed keywords

EID: 34848890572     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02980245     Document Type: Article

References (21)

1. Acquas, E., Carboni, E., and Di Chiara, G., Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur. J. Pharmacol., 193, 133-134 (1991).
2. Di Chiara, G. and Imperato, A., Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A., 85, 5274-5278 (1988).
3. Diana, M., Pistis, M., Muntoni, A., and Gessa, G., Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharmacol. Exp. Ther., 272, 781-785 (1995).
4. Funada, M. and Shippenberg, T. S., Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats. Behav. Pharmacol., 7, 448-453 (1996).
5. Georges, F., Stinus, L., Bloch, B., and Le Moine, C., Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur. J. Neurosci., 11, 481-490 (1999).
6. Hearn, H. G., Ren, Y., McBride, E. W., Reveillaud, I., Beinborn, M., and Kopin, A. S., A Drosophila dopamine 2-like receptor: Molecular characterization and identification of multiple alternatively spliced variants. Proc. Natl. Acad. Sci. U.S.A., 99, 14554-14559 (2002).
7. Himmler, A., Stratowa, C., and Czernilofsky, A. P., Functional testing of human dopamine D1 and D5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines. J. Recept. Res., 13, 79-94 (1993).
8. Kang, W. S., Lim, I. H., Yuk, D. Y., Chung, K. H., Park, J. B., Yoo, H. S., and Yun, Y. P., Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb. Res., 96, 229-237 (1999).
9. Kim, K. M., Valenzano, K. J., Robinson, S. R., Yao, W. D., Barak, L. S., and Caron, M. G., Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J. Biol. Chem., 276, 37409-37414 (2001).
10. Koob, G. F. and Bloom, F. E., Cellular and molecular mechanisms of drug dependence. Science, 242, 715-723 (1988).
11. Lee, S. Y., Lee, J. W., Lee, H., Yoo, H. S., Yun, Y. P., Oh, K. W., Ha, T. Y., and Hong, J. T. Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain. Res. Mol. Brain. Res., 140, 45-54 (2005).
12. Maldonado, R., Blendy, J. A., Tzavara, E., Gass, P., Roques, B. P., Hanoune, J., and Schutz, G., Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science, 273, 657-659 (1996).
13. Maldonado, R., Stinus, L., Gold, L. H., and Koob, G. F., Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther., 261, 669-677 (1992).
14. Matsuoka, I., Maldonado, R., Defer, N., Noel, F., Hanoune, J., and Roques, B. P., Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur. J. Pharmacol., 268, 215-221 (1994).
15. Neal, B. S. and Sparber, S. B., Mianserin attenuates naloxone- precipitated withdrawal signs in rats acutely or chronically dependent upon morphine. J. Pharmacol. Exp. Ther., 236, 157-165 (1986).
16. Noguchi, M. Yokoyama, M., Watanabe, S., Uchiyama, M. Nakao, Y., Hara, K., and Iwasaka, T., Inhibitory effect of the tea polyphenol, (-)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines. Cancer. Lett., 234, 135-142 (2006).
17. Nowycky, M. C., Walters, J. R., and Roth, R. H., Dopaminergic neurons: effect of acute and chronic morphine administration on single cell activity and transmitter metabolism. J. Neural. Transm., 42, 99-116 (1978).
18. Regunathan, S. and Reis, D. J., Effects of moxonidine, an imidazoline antihypertensive agent, on second messenger systems in rat brain. Eur. J. Pharmacol., 269, 273-276 (1994).
19. Sharma, S. K., Klee, W. A., and Nirenberg, M., Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U.S.A., 72, 3092-3096 (1975).
20. Tagashira, E., Kachur, J. F., Carter, W. H., and Jr., Dewey, W. L., Potentiation of narcotic-induced antinociception by tripelennamine in morphine-tolerant and drug-naive mice. J. Pharmacol. Exp. Ther., 229, 214-217 (1984).
21. Williams, J. T., Christie, M. J., and Manzoni, O., Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev., 81, 299-343 (2001).